Skip to content

Nan Fung Group Holdings Ltd

Follow

13F filer, CIK 1782539, KAI TAK, Hong Kong

Nan Fung Group Holdings Ltd reported $149,667,138 across 29 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 75.68% of the portfolio.

Accepted , ingested 13F-HR 0001012975-26-001047

Period
2026-09-30
Reported value
$150M
Holdings
29
Top 10 weight
75.68%
New
5
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MPLTadded+1,329,075$13.5M
OBXnew+918,765$12.6M
NUVBnew+1,327,224$7.43M
NAMSnew+164,986$4.01M
TCGXnew+200,000$2.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RXRXreduced-413,656-$1.71M
CHYMexited-21,075-$432K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001012975-26-001047, largest first. % of portfolio is the value over $149,667,138, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 630,657 shares; 2026Q2: 630,657 shares; 2026Q3: 630,657 shares 630,657$24.2M16.17%0Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 971,253 shares; 2026Q1: 971,253 shares; 2026Q2: 971,253 shares; 2026Q3: 2,300,328 shares 2,300,328$23.4M15.66%+1,329,075Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 918,765 shares 918,765$12.6M8.43%newTimeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 460,000 shares; 2026Q1: 460,000 shares; 2026Q2: 987,222 shares; 2026Q3: 987,222 shares 987,222$12.1M8.11%0Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,441,032 shares; 2026Q1: 1,441,032 shares; 2026Q2: 1,441,032 shares; 2026Q3: 1,441,032 shares 1,441,032$11.9M7.95%0Timeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,327,224 shares 1,327,224$7.43M4.97%newTimeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 67,022 shares; 2025Q1: 59,022 shares; 2025Q2: 59,022 shares; 2025Q3: 59,022 shares; 2025Q4: 59,022 shares; 2026Q1: 53,742 shares; 2026Q2: 53,742 shares; 2026Q3: 53,742 shares 53,742$6.52M4.36%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 19,997 shares; 2025Q1: 15,722 shares; 2025Q2: 15,722 shares; 2025Q3: 15,722 shares; 2025Q4: 15,722 shares; 2026Q1: 15,722 shares; 2026Q2: 15,722 shares; 2026Q3: 15,722 shares 15,722$5.75M3.84%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 49,120 shares; 2025Q1: 49,120 shares; 2025Q2: 49,120 shares; 2025Q3: 49,120 shares; 2025Q4: 49,120 shares; 2026Q1: 49,120 shares; 2026Q2: 49,120 shares; 2026Q3: 49,120 shares 49,120$4.68M3.12%0Timeline
PCORPROCORE TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 53,299 shares; 2026Q1: 53,299 shares; 2026Q2: 53,299 shares; 2026Q3: 88,832 shares 88,832$4.59M3.07%+35,533Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 164,986 shares 164,986$4.01M2.68%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 19,253 shares; 2025Q1: 19,253 shares; 2025Q2: 19,253 shares; 2025Q3: 19,253 shares; 2025Q4: 19,253 shares; 2026Q1: 19,253 shares; 2026Q2: 19,253 shares; 2026Q3: 19,253 shares 19,253$3.95M2.64%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,875 shares; 2025Q1: 30,875 shares; 2025Q2: 30,875 shares; 2025Q3: 30,875 shares; 2025Q4: 30,875 shares; 2026Q1: 30,875 shares; 2026Q2: 30,875 shares; 2026Q3: 30,875 shares 30,875$3.45M2.31%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,600 shares; 2026Q3: 13,600 shares 13,600$3.1M2.07%0Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 11,122 shares; 2025Q1: 11,872 shares; 2025Q2: 11,872 shares; 2025Q3: 11,872 shares; 2025Q4: 11,872 shares; 2026Q1: 5,672 shares; 2026Q2: 5,672 shares; 2026Q3: 5,672 shares 5,672$2.86M1.91%0Timeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 436,378 shares; 2025Q1: 514,702 shares; 2025Q2: 514,702 shares; 2025Q3: 514,702 shares; 2025Q4: 514,702 shares; 2026Q1: 350,745 shares; 2026Q2: 300,565 shares; 2026Q3: 300,565 shares 300,565$2.81M1.88%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 430 shares; 2025Q1: 2,800 shares; 2025Q2: 2,800 shares; 2025Q3: 2,800 shares; 2025Q4: 2,800 shares; 2026Q1: 2,800 shares; 2026Q2: 2,800 shares; 2026Q3: 2,800 shares 2,800$2.68M1.79%0Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000$2.5M1.67%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,300 shares; 2026Q2: 28,300 shares; 2026Q3: 28,300 shares 28,300$2.25M1.5%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 102,984 shares; 2025Q1: 102,984 shares; 2025Q2: 102,984 shares; 2025Q3: 102,984 shares; 2025Q4: 102,984 shares; 2026Q1: 102,984 shares; 2026Q2: 102,984 shares; 2026Q3: 102,984 shares 102,984$2.08M1.39%0Timeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 81,376 shares 81,376$1.64M1.1%newTimeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 368,665 shares; 2025Q1: 368,665 shares; 2025Q2: 368,665 shares; 2025Q3: 27,049 shares; 2025Q4: 27,049 shares; 2026Q1: 27,049 shares; 2026Q2: 27,049 shares; 2026Q3: 27,049 shares 27,049$1.06M0.71%0Timeline
ETHAISHARES ETHEREUM TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,549 shares; 2025Q4: 50,549 shares; 2026Q1: 50,549 shares; 2026Q2: 50,549 shares; 2026Q3: 50,549 shares 50,549$1.02M0.68%0Timeline
IBITISHARES BITCOIN TRUST ETFQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,968 shares; 2025Q4: 15,968 shares; 2026Q1: 15,968 shares; 2026Q2: 15,968 shares; 2026Q3: 15,968 shares 15,968$756K0.51%0Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,580 shares; 2026Q2: 6,580 shares; 2026Q3: 6,580 shares 6,580$751K0.5%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 664,610 shares; 2025Q1: 664,610 shares; 2025Q2: 664,610 shares; 2025Q3: 595,287 shares; 2025Q4: 595,287 shares; 2026Q1: 595,287 shares; 2026Q2: 595,287 shares; 2026Q3: 181,631 shares 181,631$750K0.5%-413,656Timeline
RANIRANI THERAPEUTICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 493,584 shares; 2025Q1: 493,584 shares; 2025Q2: 493,584 shares; 2025Q3: 493,584 shares; 2025Q4: 493,584 shares; 2026Q1: 493,584 shares; 2026Q2: 493,584 shares; 2026Q3: 493,584 shares 493,584$390K0.26%0Timeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 49,082 shares; 2025Q1: 49,082 shares; 2025Q2: 49,082 shares; 2025Q3: 49,082 shares; 2025Q4: 49,082 shares; 2026Q1: 49,082 shares; 2026Q2: 49,082 shares; 2026Q3: 49,082 shares 49,082$312K0.21%0Timeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,347 shares; 2025Q3: 58,347 shares; 2025Q4: 58,347 shares; 2026Q1: 29,250 shares; 2026Q2: 5,000 shares; 2026Q3: 5,000 shares 5,000$18.4K0.01%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CHYMCHIME FINL INC21,075$432Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001012975-26-001047 base2026-11-13